Select <scp>HDAC</scp> Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy-Reference-Cited by-同舟云学术

Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy

Published:2023-01-25 Issue:3 Volume:7 Page:
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Clements Miranda E¹²,Holtslander Lauren²³,Johnson Joshua R²³,Johnson Rachelle W¹²³^ORCID

Affiliation:

1. Program in Cancer Biology Vanderbilt University Nashville TN USA

2. Vanderbilt Center for Bone Biology, Department of Medicine, Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN USA

3. Department of Medicine, Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN USA

Funder

U.S. Department of Defense

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm4.10694

Reference43 articles.

1. Cancer to bone: a fatal attraction

2. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study

3. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer

4. Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

5. Cancer Treatment and Bone Health

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic control of the vicious cycle;Journal of Bone Oncology;2024-02

2. ING1 inhibits Twist1 expression to block EMT and is antagonized by the HDAC inhibitor vorinostat;European Journal of Cell Biology;2023-09